Biotech · Private company
Evelo Biosciences, Inc.
Track this companyFree. Adds Evelo Biosciences, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials60 recruiting or active
Pipeline programs5From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline5
- EDP1815Phase 2 · Atopic DermatitisClinicalTrials.gov · fetched Nov 12, 2026
- EDP1815Phase 2 · Covid19ClinicalTrials.gov · fetched Nov 12, 2026
- EDP1815Phase 2 · PsoriasisClinicalTrials.gov · fetched Nov 12, 2026
- EDP1503Phase 1 · Colorectal Cancer MetastaticClinicalTrials.gov · fetched Nov 12, 2026
- PembrolizumabPhase 1 · Colorectal Cancer MetastaticClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials6
- A Long-Term Extension Trial in Participants With Atopic Dermatitis Who Participated in Previous EDP1815 TrialsPHASE2 · TERMINATED · started Jun 6, 2022ClinicalTrials.gov NCT05439941 · fetched Nov 12, 2026
- A Study Investigating the Effect of EDP1815 in the Treatment of Mild, Moderate and Severe Atopic DermatitisPHASE2 · COMPLETED · started Jan 31, 2022ClinicalTrials.gov NCT05121480 · fetched Nov 12, 2026
- A Phase 2 Study Investigating the Effect of EDP1815 in the Treatment of Mild to Moderate Plaque PsoriasisPHASE2 · COMPLETED · started Sep 21, 2020ClinicalTrials.gov NCT04603027 · fetched Nov 12, 2026
- Safety and Efficacy of EDP1815 in the Treatment of Patients Hospitalized With COVID-19 InfectionPHASE2 · TERMINATED · started Aug 26, 2020ClinicalTrials.gov NCT04488575 · fetched Nov 12, 2026
- A Study of EDP1503 in Patients With Colorectal Cancer, Breast Cancer, and Checkpoint Inhibitor Relapsed TumorsPHASE1 · COMPLETED · started Dec 19, 2018ClinicalTrials.gov NCT03775850 · fetched Nov 12, 2026
- Pembrolizumab and EDP1503 in Advanced MelanomaPHASE2 · TERMINATED · started Oct 2, 2018ClinicalTrials.gov NCT03595683 · fetched Nov 12, 2026